A new guide to win the crypto in 2025

While the cryptocurrency market continues to mature and technological innovation continues, the 2025 investment landscape presents new opportunities for retail and professional sales merchants. Among these, directly winning the stable USDT through Ethereum Mining quickly becomes a popular strategy. It combines the mining potential of the second global cryptocurrency with the stability of the USDT,…

Read More

SpacePay Makes Crypto Payments Easier: What Nearly $1 Million in Presale Funding Shows About Its Future

SpacePay is changing the way we use crypto for everyday purchases by making digital payments as easy as using a credit card. The platform connects over 325 crypto wallets to standard payment terminals, allowing customers to pay with their preferred digital currency while merchants receive local currency instantly. The platform’s success comes from solving real-world…

Read More

AMD’s AI Chip Sales Might Disappoint in 2025

Advanced microdevices (AMD 2.55%) establishes itself as the No. 2 player in the artificial intelligence (AI) accelerator market, even if it remains far behind Nvidia. While Nvidia now generates $30 billion per quarter in its data center segment, AMD said it expects to produce about $5 billion from AI accelerator sales in all of 2024….

Read More

Democrats boycott the crypto audience; The Senate launches Trump Corruption Investigation – Ledger Insights

Yesterday, American Democrats increased their response to President Trump’s family involvement in the cryptocurrency sector and the appearance of conflicts of interest. The waters of the members of the Democrats of the Chamber of Financial Services Committee came out at the start of a joint audience With the Agriculture Committee on digital assets, several other…

Read More

Researchers use AI to help repurpose drugs to treat rare diseases

Rare and undiagnosed diseases affect more than 300 million people worldwide, representing an immense human and economic burden. These conditions, although rare individually, collectively represent an enormous health challenge. Despite the urgency, only 5 to 7 percent of these diseases have an FDA-approved drug, leaving many patients without effective treatment options. A revolutionary artificial intelligence…

Read More